Huron Consulting Group Inc. (HURN)
Valor JustoFundamental
70
Preço
$156.83
Capitalização de Mercado
$2.50B
Parte 1 · Quanto vale a empresa
Visão Geral
Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improvement consulting services; digital services; spanning technology and analytic-related services, including enterprise health record, enterprise resource planning, enterprise performance management, customer relationship management, data management, artificial intelligence and automation, technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. It also provides research-focused consulting and managed services, as well as Huron Research product suite, a software suite designed to facilitate and improve research administration service delivery and compliance. In addition, the company offers software products, financial capital advisory services, regulatory compliance and risk management consulting, and Commercial consulting. The company serves healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18 de setembro de 2026 with claude-haiku-4-5 — shared with all users
Guidehouse, which absorbed Navigant's healthcare practice, sells the same hospital and health-system performance improvement, revenue cycle and research administration advisory that Huron's Healthcare and Education segments live on.
Chartis is a pure-play healthcare advisory firm bidding for the same strategy, clinical and operational transformation projects at US hospitals and academic medical centers that make up Huron's largest segment.
FTI's corporate finance and business transformation practice competes with Huron for performance improvement, restructuring and financial advisory mandates from the same US corporate and healthcare clients.
Accenture competes head-on with Huron's Digital capability, implementing the same Oracle, Workday and Salesforce platforms for health systems and universities, with far greater scale.
Deloitte's healthcare and higher-education consulting practices pursue the same hospital and university transformation budgets, and Huron's 10-K names the consulting arms of the major accounting firms among its competitors.
ICF sells advisory and technology implementation services to public-sector, health and research institutions, overlapping with Huron's Education and Commercial segments.
Balanço & Liquidez
Receita
$1.75B
Últimos 12 meses (até 31/03/2026)
Resultado Líquido
$104M
Últimos 12 meses (até 31/03/2026)
Fluxo de Caixa Livre
$183M
Capital Próprio Total
$529M
Passivo Total
$998M
Rácio de Liquidez
2.22
Cobertura de Juros
-
Dívida/EBITDA
4.21
Resultados Por Ação
Receita & Resultado Líquido
Fluxo de Caixa Livre
Decomposição dos Resultados
Demonstração histórica
Margens ao longo do tempo
A dívida ao longo do tempo
Quanto pesa a dívida
Grelha do crescimento
Crescimento — Receitas
Estimativa de Valor Justo
Valor Justo
$183.81
Preço Atual
$156.83
Margem de Segurança
+14.7%
Intervalo de Valor Justo
$119.48 - $248.15
Dispersão entre os métodos de avaliação utilizados, não um intervalo de confiança calibrado estatisticamente.
Métodos de Estimativa
Métricas de Avaliação
Rácio P/E
26.81
ROE
19.9%
Rácio P/B
6.40
P/FCF
20.54
Margem Bruta
-
ROIC
10.6%
Radar de Rentabilidade
Criação de Valor (Vantagem Competitiva)
ROIC
10.6%
WACC
5.9%
ROIC − WACC
+4.7 pp
O ROIC supera o custo do capital — a empresa está a criar valor para os acionistas.
Critérios de Análise Fundamental
Aprovado (18)
- EPS shows upward trend
- EPS CAGR 15.16%
- Price CAGR 12.19%
- ROIC 10.6%
- P/FCF 20.54
- Debt/Equity ratio
- Operating Margin 10.4%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 25.5%
- Revenue Growth 5Y 14.3%
- Analyst Consensus 91% Buy
- Earnings Surprise avg 9.0%
- Earnings Quality (OCF/NI) 1.33
- Share Dilution -3.3%
Reprovado (6)
- P/B Ratio 6.40
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Net Margin Trend 5.9% vs 7.9%
- Piotroski F-Score 4/9
Indisponível (4)
- Gross Margin NaN%
- Dividend Payout NaN%
- Interest Coverage
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Sinais mistos: algumas áreas requerem atenção
Qualidade dos Resultados
Alta qualidade: resultados respaldados por caixa
Diluição de Ações
A recomprar ações. Favorável ao acionista
Participações institucionais
Governação
Equipa Executiva
| Nome | Cargo | Idade |
|---|---|---|
| Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A. | President, CEO & Director | 64 |
| Mr. John D. Kelly CPA, M.S. | Executive VP, CFO & Treasurer | 48 |
| Mr. J. Ronald Dail | Executive VP & COO | 54 |
| Ms. Hope E. Katz J.D. | Executive VP, General Counsel & Corporate Secretary | - |
| Mr. Kyle D. Featherstone | Chief Accounting Officer & Corporate VP | 44 |
| Mr. Sean Freeburger | Chief Information Officer | - |
| Allie Bovis | Director of Communications | - |
| Elizabeth Entinghe | Corporate Vice President of Corporate Development | - |
| Sarah McHugh | Corporate VP & Chief Marketing Officer | - |
| Ms. Kristen Bruner | Chief Human Resources Officer & Corporate VP | - |
Risco de Auditoria
1
Risco do Conselho
3
Risco de Remuneração
3
Risco dos Direitos dos Acionistas
6
Parte 2 · O preço e o momento de entrar
Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.
Documentos
- Ver documento
Relatório anual (10-K)
Uma visão anual do negócio, dos resultados financeiros e dos riscos da empresa.
Arquivado em 2026-02-24
- Ver documento
Relatório trimestral (10-Q)
Uma atualização sobre o desempenho financeiro dos últimos três meses.
Arquivado em 2026-07-28
- Ver documento
Relatório de fato relevante (8-K)
Um aviso sobre um fato relevante, como uma mudança na liderança ou um grande anúncio.
Arquivado em 2026-07-28
via SEC EDGAR
Histórico de Resultados
via SEC EDGAR
Latest News
Recent headlines for HURN, sourced from Markets Gazette.
- 5/5/2026NEUTRALHuron Consulting Gr Q1 2026 Earnings Call Transcript
Huron Consulting Group Inc. (HURN) released its Q1 2026 Earnings Call Transcript on May 5, 2026. The transcript provides detailed insights into the company's financial performance, strategic initiatives, and outlook for the upcoming quarters. While specific financial figures and forward-looking statements are discussed, the transcript itself is an informational document rather than a direct announcement of new performance data or significant strategic shifts that would immediately impact the stock price. Investors can use this transcript to gain a deeper understanding of management's perspective and the underlying business drivers.
via Markets Gazette